高灵敏度流式细胞术显示早期B细胞亚群耗竭与利妥昔单抗5年应答相关,而B细胞清除失败发生于后续多重难治性疾病的早期阶段
该单中心真实世界队列纳入232例接受利妥昔单抗治疗的类风湿关节炎成人患者,于基线及2周时行高灵敏度流式细胞术评估B细胞亚群。2周浆母细胞完全耗竭与1年应答及5年利妥昔单抗持续使用正相关,而早期记忆B细胞清除不完全则与多重难治性RA相关。
要点
- 2周浆母细胞完全耗竭与5年利妥昔单抗持续使用正相关。
- 2周浆母细胞计数较高与1年应答及5年持续使用几率降低相关。
- 多重难治性RA早期即显示2周记忆B细胞水平较高且与难治程度相关。
核心结论
- 2周时高灵敏度流式细胞术检测的浆母细胞耗竭与5年利妥昔单抗持续使用强相关,而记忆B细胞清除不完全则提示多重难治性RA。
研究设计与样本
- 单中心真实世界队列,纳入232例接受利妥昔单抗治疗的类风湿关节炎成人患者,于基线及2周时行外周血高灵敏度流式细胞术评估。
主要发现
- 2周完全耗竭率:初始B细胞91%,记忆B细胞92%,浆母细胞69%。
- 2周浆母细胞完全耗竭与1年应答及5年持续使用均正相关。
关键数值与推荐
- 完全耗竭定义为计数<0.1 cells/µL。
- 1年应答定义为简化疾病活动指数≤11且在6个月内达到并维持≥12个月。
- 5年利妥昔单抗持续使用定义为维持应答且无治疗改变≥5年。
临床怎么用
- 高灵敏度流式细胞术可用于早期识别利妥昔单抗应答不佳及多重难治性RA患者。
- 2周浆母细胞耗竭状态有助于预测利妥昔单抗长期持续使用。
局限性
- 原文为单中心真实世界队列,未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess complete depletion of B-cell subsets using high-sensitivity flow cytometry (HSFC) across the therapeutic spectrum of rheumatoid arthritis (RA): from good initial rituximab (RTX) responders to poly-refractory RA (failed all biologic or targeted synthetic disease-modifying antirheumatic drug classes). METHODS: Single-centre real-world cohort of 232 RTX-treated RA adults undergoing peripheral blood HSFC assessment at baseline (before the first RTX infusion) and after 2 weeks (2W). Naïve, memory B cells and plasmablasts were quantified; complete depletion was defined as counts < 0.1 cells/µL. One-year response (simplified disease activity index ≤11 within 6 months, maintained for ≥ 12 months) and 5-year RTX persistence (maintained response with no therapeutic change for ≥ 5 years) were assessed. Longitudinal B-cell trajectories with multiple RTX cycles were analysed. RESULTS: 2W complete depletion rates were 91% for naïve, 92% for memory B cells, and 69% for plasmablasts. Higher 2W plasmablast counts were associated with lower odds of 1-year response (odds ratio [OR], 0.50; 95%CI, 0.32-0.75; P = .001) and 5-year RTX persistence (OR, 0.48; 95%CI, 0.30-0.79; P = .004); complete plasmablast depletion at 2W was positively associated with both outcomes. Early during disease, poly-refractory RA (n=31; 13%) showed higher 2W memory B-cell levels, and counts were associated with increasing refractoriness (OR, 1.9; 95%CI, 1.3-2.9; P = .003). Across multiple cycles, sustained suppression of memory B cells and plasmablasts were seen in patients showing RTX persistence. CONCLUSIONS: 2W plasmablast depletion on HSFC is strongly linked to 5-year RTX retention, while incomplete memory B-cell depletion characterises poly-refractory RA. Thus, responsiveness and refractoriness in RA are linked to B-cell pathology, endorsing HSFC implementation in selecting novel B-cell targeting strategies and early recognition of refractory disease.
引用
- Tonutti A, Abacar K, David P, et al. High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease. Ann Rheum Dis. 2026. PMID: 42580905. doi:10.1016/j.ard.2026.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。